ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,201Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 286

$1.03M Total Retail Price of All Prescriptions

Rank: 15 out of 286

737 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 737 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 8,359 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 48%.

Prescription Price

$92 was the average price of a prescription from this provider, compared to $149 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 2,498 1,883 1 1
SYNTHROID 358 297 2 2
SIMVASTATIN 284 224 3 8
METFORMIN HCL ER 259 211 4 14
PEN NEEDLE 257 151 5 4
LANTUS 244 152 6 6
INSULIN SYRINGE 240 189 7 9
NOVOLOG 220 154 8 16
ATORVASTATIN CALCIUM 217 173 9 15
GLIMEPIRIDE 216 161 10 7
HUMALOG 206 121 11 10
LISINOPRIL 200 163 12 11
NOVOLOG FLEXPEN 191 88 13 13
METHIMAZOLE 188 142 14 24
LANTUS SOLOSTAR 168 99 15 5
LEVEMIR FLEXPEN 163 64 16 20
NOVOLOG MIX 70-30 FLEXPEN 121 85 17 26
AMLODIPINE BESYLATE 117 107 18 19
METFORMIN HCL 116 74 19 3
LEVEMIR 114 87 20 33
GLYBURIDE-METFORMIN HCL 104 64 R 21 44
PREDNISONE 101 71 22 95
JANUVIA 95 81 23 12
RAMIPRIL 95 66 23 55
METOPROLOL SUCCINATE 94 80 25 37
POTASSIUM CHLORIDE 89 79 26 46
FUROSEMIDE 85 75 27 30
HUMALOG MIX 75-25 85 56 27 42
PRAVASTATIN SODIUM 84 60 29 18
CALCITRIOL 81 69 30 77
CLOPIDOGREL 80 63 31 66
HUMULIN N 77 46 32 27
METOPROLOL TARTRATE 73 68 33 56
LEVOXYL 71 70 34 21
ALLOPURINOL 69 43 35 81
OMEPRAZOLE 66 47 36 47
HYDROCORTISONE 66 23 36 54
CRESTOR 66 61 36 17
CIPROFLOXACIN HCL 65 60 39 137
GABAPENTIN 65 58 39 23
NOVOLOG MIX 70-30 65 64 39 51
SURE COMFORT 59 39 42 78
ACTOS 59 55 42 28
LIOTHYRONINE SODIUM 57 37 44 58
SPIRONOLACTONE 55 33 45 86
PLAVIX 55 44 45 75
ZETIA 51 51 47 36
NOVOLIN N 51 35 47 60
HYDROCODONE-ACETAMINOPHEN 50 30 S3 49 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.